Vasilios F Diakonis

Dr. Vasilios F Diakonis


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
GKGeorge Kymionis
George Kymionis
DPDimitra M. Portaliou
Dimitra M. Portaliou
VDVasilios F Diakonis
Vasilios F Diakonis
GKGeorge A. Kounis
George A. Kounis
SPSophia I. Panagopoulou
Sophia I. Panagopoulou
MGMichael A. Grentzelos
Michael A. Grentzelos

1 September 2012 in Ophthalmology
Verified
Journal Article
Closed access
GKGeorge Kymionis
George Kymionis
MGMichael A. Grentzelos
Michael A. Grentzelos
GKGeorge A. Kounis
George A. Kounis
VDVasilios F Diakonis
Vasilios F Diakonis
ALAliki N. Limnopoulou
Aliki N. Limnopoulou
SPSophia I. Panagopoulou
Sophia I. Panagopoulou

1 May 2009 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
GKGeorge Kymionis
George Kymionis
VDVasilios F Diakonis
Vasilios F Diakonis
MKMaria Kalyvianaki
Maria Kalyvianaki
DPDimitra Portaliou
Dimitra Portaliou
CSCharalampos Siganos
Charalampos Siganos
APAristophanis I. Pallikaris
Aristophanis I. Pallikaris

1 July 2020 in Eye and Brain
Verified
Journal Article
Open access
PDF file
GTGeorgios Tsokolas
Georgios Tsokolas
KTKonstantinos Tsaousis
Konstantinos Tsaousis
VDVasilios F Diakonis
Vasilios F Diakonis
AMArtemis Matsou
Artemis Matsou
STStraton Tyradellis
Straton Tyradellis
Background: Optical coherence tomography angiography (OCT-A) has emerged as a novel, fast, safe and non-invasive imaging technique of analyzing the retinal and choroidal microvasculature in vivo. OCT-A captures multiple sequential B-scans performed repeatedly over a specific retinal area at high speed, thus enabling the composition of a vascular map with areas of contrast change (high flow zones) and areas of steady contrast (slow or no flow zones). It therefore provides unique insight into the exact retinal or choroidal layer and location at which abnormal blood flow develops. OCTA has evolved into a useful tool for understanding a number of retinal pathologies such as diabetic retinopathy, age-related macular degeneration, central serous chorioretinopathy, vascular occlusions, macular telangiectasia and choroidal neovascular membranes of other causes. OCT-A technology is also increasingly being used in the evaluation of optic disc perfusion and has been suggested as a valuable tool in the early detection of glaucomatous damage and monitoring progression. Objective: To review the existing literature on the applications of optical coherence tomography angiography in neurodegenerative diseases. Summary: A meticulous literature was performed until the present day. Google Scholar, PubMed, Mendeley search engines were used for this purpose. We used 123 published manuscripts as our references. OCT-A has been utilized so far to describe abnormalities in multiple sclerosis (MS), Alzheimer’s disease, arteritic and non-arteritic optic neuropathy (AION and NAION), Leber’s hereditary optic neuropathy (LHON) papilloedema, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), Wolfram syndrome, migraines, lesions of the visual pathway and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). It appears that OCT-A findings correlate quite well with the severity of the aforementioned diseases. However, OCT-A has its own limitations, namely its lack of wide-field view of the peripheral retina and the inaccurate interpretation due to motion artifacts in uncooperative groups of patients (e.g. children). Larger prospective longitudinal studies will need to be conducted in order to eliminate the aforementioned limitations.

1 November 2006 in Ophthalmology
Verified
Journal Article
Closed access
GKGeorge Kymionis
George Kymionis
NTNikolaos S. Tsiklis
Nikolaos S. Tsiklis
APAristofanis I. Pallikaris
Aristofanis I. Pallikaris
GKGeorge Kounis
George Kounis
VDVasilios F Diakonis
Vasilios F Diakonis
CSCharalambos S. Siganos
Charalambos S. Siganos

1 January 2013 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
GKGeorge Kymionis
George Kymionis
VKVardhaman P Kankariya
Vardhaman P Kankariya
VDVasilios F Diakonis
Vasilios F Diakonis
SYSonia H Yoo
Sonia H Yoo
Pediatric keratoconus demonstrates several distinctive management issues in comparison with adult keratoconus with respect to under-diagnosis, poor compliance and modifications in treatment patterns. The major concerns comprise of the accelerated progression of the disease in the pediatric age group and management of co-morbidities such as vernal keratoconjuntivitis. Visual impairment in pediatric patients may affect social and educational development and overall negatively impact their quality of life. The treatment algorithm between adults and pediatric keratoconus has been similar; comprising mainly of visual rehabilitation with spectacles, contacts lenses (soft or rigid) and keratoplasty (lamellar or penetrating) depending on the stage of the disease. There is a paradigm shift in the management of keratoconus, a new treatment modality, corneal collagen crosslinking (CXL), has been utilized in adult keratoconic patients halting the progression of the disease. CXL has been utilized for over a 10 year period and based on the evidence of efficacy and safety in the adult population; this treatment has been recently utilized in management of pediatric keratoconus. This article will present an update about current management of pediatric keratoconus with special focus on CXL in this age group.